other material
confidence high
sentiment neutral
materiality 0.75
Vera Therapeutics launches $300M public offering of 7.1M shares at $42.00
Vera Therapeutics, Inc.
- 7,142,858 shares offered at $42.00/share; gross proceeds ~$300M before discounts and expenses.
- Underwriters have 30-day option to purchase up to 1,071,428 additional shares at the same price.
- Closing expected October 31, 2024; J.P. Morgan, Goldman Sachs, Evercore, Cantor Fitzgerald are underwriters.
- Offering made under automatic shelf registration statement on Form S-3; customary closing conditions apply.